Fibromyalgia Treatments Market Research Report- Global Forecast To 2022

Fibromyalgia Treatments Market Research Report- Global Forecast To 2022

ID: MRFR/HC/1347-HCRR | January, 2018 | Region: Global | 85 pages | Half-Cooked Research Reports

Fibromyalgia Treatments Market Information, by Types of treatments (pain relievers, antidepressants, anti-seizure drugs, therapy) by end users (Hospitals and Clinics, Research Centers, laboratories) - Forecast to 2022


Study objectives of the Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the fibromyalgia treatments market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to the main geography and its countries - North America, Europe, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by types of treatment, by end users, and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the market.


Fibromyalgia Treatments market, by types of treatment:



Intended Audience



  • Fibromyalgia Disease Drugs manufacturers & suppliers

  • Pharmaceutical and Biotechnology companies

  • Hospitals and Laboratories

  • Academic Research Institutes



Market Synopsis of the Market:
Market Scenario:
Fibromyalgia is a disease which affects the soft tissues and the muscles. The symptoms for the following disease include fatigue, chronic muscle pain, sleeping problems, trigger points etc. Treatments include medications, therapy, lifestyle treatment and others. Globally the market for Fibromyalgia Disease is expected to grow at the rate of about XX% from 2016 to 2022.



Key Finding



  • The European market is expected to reach $XX million by 2022.

  • Anti-Seizure Drugs holds the largest share of XX% of the fibromyalgia treatments market.

  • North America holds the largest market share of XX% of fibromyalgia treatments and is expected to reach $XX million by the end of forecast period.

  • Asia-Pacific is expected to be the fastest growing market at a CAGR of XX%



Segments:
                                                                                                                                      
Fibromyalgia treatments market has been segmented on the basis of types of treatments which comprises of pain relievers, antidepressants, anti-seizure drugs, therapy and others. On the basis of end users the market is segmented into hospitals and clinics, research centres, laboratories and others



Regional Analysis of the Market:  
                                                                           
Globally North America is the largest market for fibromyalgia treatments. Europe is the second-largest market and Asia Pacific is expected to grow at a rapid rate.



Key Players for the Market:  
                                                                         
Some of the key players in this market are: A&S Pharmaceutical Corp, Leiner Health Products, Inc., LNK International, Inc., Pharmaceutical Formulations, Inc., Bayer Healthcare, Sanofi, Endo International, Johnson & Johnson, Purdue Pharma, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Pfizer Inc., and Merck & Co., Inc.        



North America



  • US

  • Canada


Europe


  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • U.K

  • Rest of Western Europe

  • Eastern Europe


Asia–Pacific


  • Asia

  • China

  • India

  • Japan

  • South Korea

  • Rest of Asia Pacific


Middle East& Africa


The report for F
ibromyalgia Treatments Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



Table Of Content

1    Introduction

      1.1    Definition

      1.2    Scope of Study

      1.3    Research Objective

      1.4    Assumptions & Limitations

      1.5    Market Structure

2    Research Methodology

      2.1    Research Process

      2.2    Primary Research

      2.3    Secondary Research

3    Market Dynamics

      3.1    Drivers

      3.2    Restraints

      3.3    Opportunities

      3.4    Challenges

      3.5    Macroeconomic Indicators

4    Market Factor Analysis

      4.1    Porter’s five forces model

            4.1.1    Bargaining Power of suppliers

            4.1.2    Bargaining Power of Customer

            4.1.3    Intensity of Competitor’s

            4.1.4    Threat of New Entrants



5    Global Fibromyalgia Treatment Market, by Types of Treatment     

      5.1    Introduction

            5.1.1    Pain relievers

            5.1.2    Antidepressants

            5.1.3    Anti-seizure drugs    

            5.1.4    Therapy

            5.1.5    Others

6    Global Fibromyalgia Treatment Market, by End Users    

      6.1    Introduction

            6.1.1    Hospitals and Clinics

            6.1.2    Research Centre

            6.1.3    Laboratories

            6.1.4    Others

7    Global Fibromyalgia Treatment Market, by regions

      7.1    Introduction

            7.1.1    North America    

                7.1.1.1    US

                7.1.1.2    Canada

            7.1.2    Europe

                7.1.2.1    Germany

                7.1.2.2    France

                7.1.2.3    UK

                7.1.2.4    Italy

                7.1.2.5    Spain

                7.1.2.5    Rest of Europe

            7.1.3    Asia Pacific

                7.1.3.1    Japan

                7.1.3.2    China

                7.1.3.3    India

                7.1.3.4    South Korea

                7.1.3.5    Rest of Asia Pacific

            7.1.4     Middle East & Africa

8    Company Landscape

      8.1    Introduction

            8.1.1    Mergers Acquisitions

            8.1.2    Collaborations

            8.1.3    Release/New Product Launches

9    Company Profile

      9.1    Bayer Healthcare

            9.1.1    Company Overview

            9.1.2    Product/Business Segment Overview

            9.1.3    Financials

            9.1.4    Key Developments

      9.2    Eli Lilly and Company

            9.2.1    Overview

            9.2.2    Product/Business Segment Overview

            9.2.3    Financials

            9.2.4    Key Developments

      9.3    Merck & Co., Inc.

            9.3.1    Overview

            9.3.2    Product/Business Segment Overview

            9.3.3    Financials

            9.3.4    Key Developments

      9.4    Pfizer Inc.

            9.4.1    Overview

            9.4.2    Product/Business Segment Overview

            9.4.3    Financials

            9.4.4    Key Developments

      9.5    Teva Pharmaceutical Industries Ltd

            9.5.1    Overview

            9.5.2    Product/Business Segment Overview

            9.5.3    Financials

            9.5.4    Key Developments

10    Appendix